Z-VAD-FMK is a broad-spectrum caspase inhibitor commonly used in research to prevent apoptosis, or programmed cell death. It is particularly useful in studies involving cell survival, where scientists aim to distinguish between apoptotic and necrotic pathways. By irreversibly binding to the active sites of caspases, it effectively blocks their activity, allowing researchers to assess the role of caspase-dependent processes in various biological systems. It is widely applied in cell culture experiments to enhance cell viability during stressful conditions such as serum deprivation, oxidative stress, or exposure to cytotoxic agents. Z-VAD-FMK is also used in models of neurodegenerative diseases, ischemia-reperfusion injury, and viral infections to investigate how inhibiting apoptosis affects disease progression. Additionally, it has been employed in immunology research to study inflammatory responses, as caspases are involved not only in apoptosis but also in the activation of inflammatory cytokines. Its cell-permeable nature makes it suitable for both in vitro and in vivo applications, especially in animal models where suppression of apoptosis is desired to evaluate tissue protection or immune modulation.